Roberto Mignone Insider Trades & Stock Holdings

Director · Teva Pharmaceutical Industries Limited · Latest filing Sep 18, 2026

Roberto Mignone, Director at Teva Pharmaceutical Industries Limited has 3 Form 4 trades on file since Jun 21, 2026 across 2 companies. Open-market activity: 0 purchases ($0) and 1 sale ($14.36M), net -$14.36M. Latest filing: disposed of 367.60K shares of $TEVA on Sep 18, 2026 at $39.06.

Trades on file

3

Open-market bought

$0

Open-market sold

$14.36M

Net open-market

-$14.36M

Latest filing

Sep 18, 2026

All insider trades by Roberto Mignone

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 18, 2026	$TEVA	Sell (Open-market sale)	367.60K	$39.06	$14.36M			+0.5%			Director		—
Jun 21, 2026	$GH	Sell (Option exercise)	264	$0	—			+19.3%	+18.2%				—
Jun 21, 2026	$GH	Buy (Option exercise)	264	$0	—			+19.3%	+18.2%				—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Roberto Mignone traded

• $GH
• $TEVA

Frequently asked questions

Has Roberto Mignone been buying or selling stock?

Roberto Mignone has 0 open-market purchases and 1 open-market sale on file, net -$14.36M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Roberto Mignone's latest insider trade?

disposed of 367.60K shares of $TEVA on Sep 18, 2026 at $39.06.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.